First Houston Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$1.06M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$663K |
| 3 |
Stanley Black & Decker
SWK
|
+$597K |
| 4 |
Eaton
ETN
|
+$526K |
| 5 |
Centene
CNC
|
+$521K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NCR Voyix
VYX
|
+$1.98M |
| 2 |
UnitedHealth
UNH
|
+$1.54M |
| 3 |
Amgen
AMGN
|
+$1.11M |
| 4 |
Apple
AAPL
|
+$904K |
| 5 |
Snap-on
SNA
|
+$658K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.66% |
| 2 | Financials | 22.79% |
| 3 | Healthcare | 9.93% |
| 4 | Communication Services | 9.23% |
| 5 | Industrials | 8.4% |
No holdings matched the selected filter criteria.
Similar funds
First Houston Capital's Q2 2017 Portfolio in Review
As of Q2 2017, First Houston Capital held 72 positions worth $100M, down 6.8% from $107M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
First Houston Capital withdrew a net $10.1M in Q2 2017, closing 7 positions and reducing 37 holdings. Its most notable exit was NCR Voyix, an estimated $1.98M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, First Houston Capital opened a new position in Thermo Fisher Scientific worth $689K.
- First Houston Capital's largest Q2 2017 buy was Thermo Fisher Scientific: 3,950 shares worth $689K.
- First Houston Capital added most to Oracle in Q2 2017, an estimated $1.06M increase.
- First Houston Capital's biggest Q2 2017 reduction was UnitedHealth, cutting an estimated $1.54M.
- First Houston Capital fully exited NCR Voyix in Q2 2017, selling an estimated $1.98M.
- First Houston Capital's ten largest holdings make up 31% of its $100M portfolio in Q2 2017.
- First Houston Capital opened 10 new positions and closed 7 in Q2 2017.
- First Houston Capital's portfolio value fell 6.8% quarter-over-quarter to $100M.
Based on First Houston Capital's 13F filing for Q2 2017, filed 7 Aug 2017.